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Abstract
Background: People with serious mental illness (SMI) have sexual health needs but there is little evidence to
inform effective interventions to address them. In fact, there are few studies that have addressed this topic for
people with SMI outside USA and Brazil. Therefore, the aim of the study was to establish the acceptability and
feasibility of a trial of a sexual health promotion intervention for people with SMI in the UK.
Method: The RESPECT study was a two-armed randomised controlled, open feasibility trial (RCT) comparing Sexual
health promotion intervention (3 individual sessions of 1 h) (I) or treatment as usual (TAU) for adults aged 18 or
over, with SMI, within community mental health services in four UK cities. The main outcome of interest was the
percentage who consented to participate, and retained in each arm of the trial, retention for the intervention, and
completeness of data collection. A nested qualitative study obtained the views of participants regarding the
acceptability of the study using individual telephone interviews conducted by lived experience researchers.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: e.c.hughes@leeds.ac.uk
1School of Healthcare, Faculty of Medicine and Health, University of Leeds,
Leeds, UK
2Centre for Applied Research in Health, School of Human and Health
Sciences, University of Huddersfield, Huddersfield, England
Full list of author information is available at the end of the article
Hughes et al. BMC Public Health         (2020) 20:1736 
https://doi.org/10.1186/s12889-020-09661-x
(Continued from previous page)
Results: Of a target sample of 100, a total of 72 people were enrolled in the trial over 12 months. Recruitment in
the initial months was low and so an extension was granted. However this extension meant that the later recruited
participants would only be followed up to the 3 month point. There was good retention in the intervention and
the study as a whole; 77.8% of those allocated to intervention (n = 28) received it. At three months, 81.9% (30 I; 29
TAU) and at 6 months, 76.3% (13 I and 16 TAU) completed the follow-up data collection. No adverse events were
reported. There was good completeness of the data. The sexual health outcomes for the intervention group
changed in favour of the intervention. Based on analysis of the qualitative interviews, the methods of recruitment,
the quality of the participant information, the data collection, and the intervention were deemed to be acceptable
to the participants (n = 22).
Conclusions: The target of 100 participants was not achieved within the study’s timescale. However, effective
strategies were identified that improved recruitment in the final few months. Retention rates and completeness of
data in both groups indicate that it is acceptable and feasible to undertake a study promoting sexual health for
people with SMI. A fully powered RCT is required to establish effectiveness of the intervention in adoption of safer
sex.
Study registration: ISRCTN Registry ISRCTN15747739 prospectively registered 5th July 2016.
Keywords: Sexual health, Sexual behavior, Mental health, Psychosis, Feasibility, Randomised controlled trial
Introduction
People who live with serious mental health illness (SMI)
are sexually active [1]; and some engage in sexual risk
behaviour (such as condom-less sex) [2]. This may ex-
plain why people with SMI are at increased risk of
Human Immunodeficiency Virus (HIV) infection [3],
sexually transmitted infections [4], unintended preg-
nancy and abortion [5] compared to the general popula-
tion. The reasons for engaging in sexual risk behaviour
may include hyper-sexuality when in an acute phase of
illness; co-occurring drug and alcohol problems, and be-
ing vulnerable to sexual coercion, exploitation and abuse
[6]. Despite these concerns, there has been a lack of at-
tention to sexual health promotion in mental health care
settings including staff avoiding the topic of sex and
reporting significant structural and personal barriers to
having conversations about sexual health [7–9]. These
barriers include lack of knowledge about sexual health
and sexual health services, concerns about the topic
causing embarrassment or distress, and a lack of local or
national policy drivers.
A number of studies have been conducted in the USA
[10] which sought to evaluate tailored sexual health in-
terventions for people with serious mental illness. These
studies were randomized trials of group interventions
(compared with treatment as usual or other time and at-
tention control) and were targeted at HIV risk behaviour
for people who have significant and long term mental
health problems. The interventions ranged from brief 2–
3 sessions [11] to a more intensive 12 session interven-
tion which was for people who were homeless and had
mental illness [12]. These studies have shown promise in
the in terms of engaging and retaining people with SMI
in the interventions, but have not always demonstrated
an impact on adoption of safer sexual practices (such as
increased use of condoms) [13].
The National Institute for Health Research (NIHR)
commissioned a feasibility study (HTA 14/172/01) to de-
velop and evaluate a bespoke sexual health intervention
targeted at those with SMI. As there had been no previ-
ous trials of this nature in the UK, the first step in the
process for evaluation of a complex intervention [14] is
to assess feasibility and acceptability in order to establish
the parameters for a fully powered trial.
Methods
Design
The RESPECT study was a pragmatic, multi-centred,
open feasibility randomised controlled trial (RCT). Par-
ticipants meeting the eligibility criteria were individually
randomised (1:1) to receive either:
 The control arm: treatment as usual (TAU) which
consisted of usual mental health care. All participants
were free to pursue reproductive health and sexual
health services via general services in their local area.
 The intervention arm: in addition to TAU,
participants took part in three sessions of sexual
health promotion, each of 1 h.
Irrespective of arm of the trial, all participants received
written information on local sexual health, contraceptive
services, some condoms, and national helplines at the
baseline appointment.
Setting
The study took place in the National Health Service
(NHS) community mental health services which provides
Hughes et al. BMC Public Health         (2020) 20:1736 Page 2 of 13
mental health support to people with severe mental ill-
ness who live in the community. People in receipt of this
service will have a named care coordinator (often a men-
tal health nurse or social worker) and will see their care
coordinator as well as other support staff as well as regu-
lar reviews by other members of the multi-disciplinary
team including psychiatrist.
Sample size
The sample size calculations were based on estimating
attrition rates and standard deviation of the primary out-
come. Assuming 30% of participants were lost to follow
up (as in the SCIMITAR pilot trial [15]) with a sample
size of 100, then the 95% confidence interval for this
level of attrition would be the observed difference ± 9
percentage points (i.e. between 21 and 39% [16];). Hence
an external pilot trial of 100 participants would ensure
robust estimates of follow-up in this population. Fur-
thermore, an external feasibility study of at least 70 mea-
sured subjects provides robust estimates of the standard
deviation of the outcome measure to inform the sample
size calculation for the subsequent larger definitive fully
powered trial.11
Recruitment
Participant eligibility
Inclusion criteria
 people on the case load of selected community
mental health services within each NHS site;
 diagnosed with a “severe mental illness” (defined as
schizophrenia, other psychosis, bipolar affective
disorder, schizoaffective disorder, major depressive
disorder);
 aged 18 and over;
 willing and able to provide written informed
consent.
Exclusion criteria
 having an acute exacerbation of their mental illness
that precluded them from active participation (as
indicated by hospitalisation and/or being under the
crisis/home treatment team at the time of
consenting);
 having a case note diagnosis that did not meet the
criteria of SMI (see inclusion);
 having a severe physical illness that precluded them
from active participation;
 a significant cognitive impairment (such as an
organic brain disorder) as determined by case notes;
 a non-English speaker (adapting the intervention is
currently beyond the scope of this study);
 lacking capacity to consent (as guided by the Mental
Capacity Act 2005);
 being unable or unwilling to give written informed
consent;
 being on the Sex Offenders Register, or having a
history of inappropriate sexual behavior*.
*as reported by the care coordinator at the time of
screening. “Inappropriate sexual behavior” was
deemed to where the person has a known history of
sexualized conversations or touching that would be
uncomfortable or distressing for the researchers.
All case managers in the selected community mental
health teams (CMHTs) were informed of the inclusion
and exclusion criteria, and were contacted regarding po-
tential participants to check that there were no areas for
concern or researcher safety (such as regarding safety of
home visits) prior to entry into the study.
Recruitment into the trial
Potentially eligible participants were identified using
three main methods: screening of caseloads of commu-
nity mental health staff for potentially eligible people;
direct approach to people using mental health services
by research staff in clinic waiting rooms, and self-referral
(via study email, telephone or via an online form on the
study website). The details for self-referral were provided
on all participant-facing materials such as the posters
and leaflets.
Flow of participants from identification to entry into
study
The numbers of people who were screened, eligible and
consented to participate were recorded where possible.
Eligible patients who did not wish to take part (i.e. un-
willing to give consent) and those found to be ineligible
went on to receive usual care from the service without
prejudice.
Informed consent and baseline assessment
Once eligibility was confirmed by mental health service,
a RESPECT researcher arranged a convenient time and
venue to meet with the potential participant to discuss
participation. The first part of the meeting involved the
researcher fully explaining the study and what would be
involved (as per information sheet) and an opportunity
for the person to ask questions and seek clarification.
Written informed consent was then obtained and base-
line data was collected (or a further date was arranged
for baseline data collection). Participants received a £10
voucher for baseline, and for each follow-up data collec-
tion point as a token of gratitude for participating.
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Trial intervention
The overall aim of the intervention was for people to
adopt safer sexual behaviours (as evidenced by reduced
condom-less sex) and engage in more positive sexual re-
lationships. The intervention was based on the Informa-
tion Motivation Behaviour (IMB) model of sexual health
behaviour change [17] and ensured that it addressed the
following:
1 Addressing any information needs using quizzes
and exercises;
2 Increase motivation to adopt safer sexual
behaviours using exercises and conversations;
3 Increase behavioural skills (and self-efficacy) to
adopt safer sexual behaviours through role play and
skills practice.
The intervention was designed to be delivered over
3 × 1-h sessions that were delivered face-to-face by a
specifically trained mental health worker. These inter-
ventionists were identified within each site and received
training and an intervention pack prior to being allo-
cated to participants. The sessions could be delivered at
the local clinical service (where the person usually
attended) or at their homes.
The manual was developed by an Intervention
Mapping process [18] using a combination of review of
existing manuals that had been developed specifically for
people with serious mental illness as well as consultation
with service users and other stakeholders. Attention was
paid to addressing the knowledge, motivational and be-
havioural and social skills deficits that have been identi-
fied as challenges to adopting safer sexual behaviours in
this group [6]. Iterations of the manual were reviewed by
stakeholders and the members of the RESPECT study
Patient and Public Involvement (PPI) representatives
and the content and format was refined based on feed-
back and discussion. The development of the interven-
tion is described in more detail in the published NIHR
final report [19]. The delivery of the topics was designed
to be interactive and used a series of quizzes, exercises
and scenarios to generate discussion. The aim of the ex-
ercises within the sessions was to facilitate discussion
about knowledge about sexual health and to supplement
the gaps in knowledge in the session or signpost people
to local sexual health and family planning services. In
terms of the theoretical underpinning of the intervention
(The IMB model) the quizzes were designed to improve
knowledge and the discussions related to own risks and
choices was designed to promote the importance of con-
sidering changing behaviour (build motivation). In
addition to developing a sense of importance of change,
the intervention used exercises and role play to increase
a sense of self-efficacy and self-worth. The role plays of
negotiation and assertiveness skills as well as the practice
of putting a condom on and off safely improved behav-
ioural skills. All participants were offered condoms and
sachets of lubricant at each session.
Summary of content:
Session 1: Knowledge regarding safer sex including HIV
and sexually transmitted infection quizzes; condoms
and contraception and where to seek help and advice
Session 2: Risky and less risky sexual behaviours for
HIV; pros and cons of condom use; behavioural skills
of using condoms (using a plastic condom
demonstrator); contingency planning for risky sexual
situations
Session 3: Focus on relationships- signs of good and
less good aspects of relationships; assertive
communication; negotiating own needs and wishes in
sexual relationships; developing an action plan for the
future.
The intervention was delivered by a mental health
worker from the NHS trust. They volunteered to sup-
port the study and were provided with 1 day training on
how to deliver the intervention facilitated by the Chief
Investigator (Hughes), and an accompanying interven-
tion manual and pack containing all the materials
needed to deliver it (copies of the manual are available
by request from lead author).
Control arm
Participants randomised to receive TAU continued to
receive their usual care. TAU for sexual health (includ-
ing contraception) included the freedom to access their
local primary care and/or specialist sexual health ser-
vices. Participants in the intervention and control arm
were offered condoms and lubricant sachets as well as a
localized list of sexual health services at baseline and
follow-up appointments.
Outcomes
The main outcome of the RESPECT study was to estab-
lish the feasibility and acceptability of an evidence-based
intervention to promote sexual health, and to establish
key parameters to inform a future main trial. In conjunc-
tion with the qualitative study, this was to be established
by measuring recruitment rates, retentions rates and fol-
low up completion rates.
Secondary outcome assessment
The following outcome measures were collected at base-
line, 3 months post randomisation and 6months post
randomisation:
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 Sexual Risk Behaviour Assessment Schedule
(SERBAS) [12]: a validated HIV risk behaviour
measure which was developed in the USA, and has
been validated for use with populations who have
serious mental illness. It gathers information on
sexual activity in the last 3 months and records
frequency of high-risk behaviours (for HIV infec-
tion) such as intercourse without a condom, sexual
activity under influence of drugs and alcohol, and
sex work/sex trading. It takes into account sexuality
and gender within the schedule.
 The National Survey of Sexual Attitudes and
Lifestyle (Natsal) [20]: We have included specific
items which cover broader aspects of sexual health
including contraception use, STI and HIV tests, and
knowledge on family planning advice.
 Knowledge about HIV (HIV-KQ) [21] a 17 item
measure that assess’ knowledge about HIV (*This
originally contained 18 item but we removed one
question about lambskin condoms as these are no
longer in use)
 Motivations to Engage in Safer Sex [21] is a 4 item
scale to assess people’s own perception of their risk
of infection with sexually transmitted infections
 Condom Self-efficacy Scale [21]: an 18 item Likert
scale to assess attitudes towards the use of condoms
as well as questions on self-efficacy in the use and
negotiation of use.
 Behavioural Intentions for Safer Sex [21]: a six-
item measure where patients are presented with
a scenario describing a possible sexual encounter
and asked to rate how likely it was that they
would engage in six risky or protective
behaviours (e.g., “I will tell the person I don’t
want to have sex without a condom”). Patients
responded to each behaviour using a 6-point
scale (ranging from 0 definitely will not do to 5
definitely will do).
 Mental illness stigma scale (MISS-Q) [22]: a 32 item
tool that has been developed and validated to
measure a person’s perceived stigma as a result of
their mental health problem and its impact on
perceptions of attractiveness and opportunities for
intimate relationships.
 EQ-5D-5L (EuroQol): a standardised instrument for
use as a measure of health outcome applicable to a
wide range of health conditions and treatments
(https://euroqol.org) (Licence permission to use in
Supplementary materials).
 The Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST) [23]: developed for the
World Health Organisation (WHO) by an
international group of substance abuse researchers
to detect and manage substance use and related
problems in primary and general medical care
settings.
 Recovering Quality of Life (ReQoL) [24]: a new 20
item patient reported outcome measure that has
been developed to assess the quality of life for
people with different mental health conditions.
 Cost assessment: Commonly used generic
instruments to measure health-related quality of life
(such as EQ-5D-5L) were used and assessed for
completion rates at various time points and patterns
of missing data. Sensitivity of generic instruments
were evaluated against sexual health-specific clinical
outcomes. A bespoke resource use questionnaire
was designed to identify the key cost drivers and can
be seen in the study report [19].
Randomisation
Randomisation was performed by a secure, remote, tele-
phone service based at York Trials Unit. An independent
statistician at the University of York undertook the gen-
eration of the randomisation sequence. Randomisation
was on a 1:1 basis using stratified block randomisation
with stratification by centre and variable block sizes.
Periodic checks were made on the computerised ran-
domisation system during the trial following standard
operating procedures:
Allocation concealment: Randomisation was done by
the researcher calling an independent person at the
York Trials Unit who entered participant details into
the trial database and the random allocation for that
person was generated.
Sequence generator: The randomisation was stratified
by study site to ensure that the balance of allocation to
intervention was evenly spread.
Blinding: Participants were randomised into the study
following completion of baseline data. Therefore, at
baseline the researcher and the participant were
blinded to the arm of the trial they would be allocated
to. However due to the nature of a behavioural
intervention compared with treatment as usual, it was
not possible for the researcher or participant to be
blinded at follow-up data collection.
Trial completion and exit
Participants were considered to have exited the trial
when they:
 withdrew consent
 had been withdrawn by interventionist/researcher
for reasons of risk or harm to self and/or others
 had reached the end of the trial
 died
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Withdrawals
Withdrawal could occur at any point during the study at
the request of the participant. When a participant
expressed that they wished to withdraw from the study,
a researcher would speak to that person to clarify the
level of withdrawal. If the participant requested to be
withdrawn from the intervention only, follow up data
continued to be collected. All data were retained for all
participants until the date of withdrawal unless they spe-
cifically requested that this be destroyed.
A participant could also be withdrawn without their
consent from the intervention and/or the trial for rea-
sons of risk or harm to self and/or others. This was only
actioned where there was evidence of serious and signifi-
cant risk and in accordance with the trial risk protocol.
Adverse events (AE)
Adverse events were monitored by an independent Data
Monitoring and Ethics Committee and the Trial Steering
Committee (TSC). The DMEC/TSC would immediately
be notified and asked to review any reported serious ad-
verse events (SAEs) that were deemed to be study and/
or intervention related.
Statistical analysis
As this was a feasibility trial, no formal analysis was
undertaken, and all analysis was descriptive. The flow of
participants is detailed in a CONSORT flow diagram.
The number of people screened, randomly assigned, re-
ceiving the intervention and providing outcome data is
summarised overall and by trial arm. The number of in-
dividuals withdrawing from the intervention and/or the
trial and any reasons for withdrawal is summarised by
trial arm. To quantify the acceptability of the interven-
tion the number of sessions attended is also summarised.
All data is presented descriptively with no formal statis-
tical analyses undertaken. For each data collection point
and outcome measure, the numbers of non-responders
is calculated and completion rates compared. The aver-
age caseload per therapist is detailed.
Health economics
Economic analysis was conducted with the aim to evalu-
ate the feasibility of collecting data on costs and health-
related quality of life outcome from the UK health
services perspective. Resource use data were collected to
estimate: i) cost of delivering the intervention; and ii)
individual-level cost of health service resource use by
trial participants over the trial follow-up period of 6
months.
Finally, analysis of the cost and health-related quality
of life data was conducted in terms of the overall re-
sponse rate for each questionnaire, rate of missing items
within each questionnaire as well as changes from
baseline to follow-up in health service resource use as
well as quality of life by treatment arm.
In addition a nested qualitative study was undertaken
with a sub-sample of participants at the end of the study
obtain qualitative data on the experience of being part of
the RESPECT study. Participants had given consent at
the start of the study to be re-contacted to be invited to
take part in individual interviews conducted by phone.
They were not interviewed by the same person who had
collected the baseline and follow-up data to avoid social
desirability responses. Lived experience researchers were
involved in this aspect of the study along with the two
main researchers. Interviews were digitally recorded and
transcribed and then coded using thematic analysis. This
nested study is described in more detail in the NIHR re-
port [19] and also in a paper in preparation (please con-
tact corresponding author for details).
Results
The flow of participants through the trial is detailed in
the CONSORT flow diagram (Fig. 1). The number of
people screened, randomly assigned, receiving the inter-
vention, completing the study protocol and providing
outcome data are summarised overall and by trial arm.
The number of individuals withdrawing from the inter-
vention and/or the trial and any reasons for withdrawal
are summarised by trial arm. To quantify the acceptabil-
ity of the intervention the number of sessions attended
is also summarised. All data is presented descriptively
with no formal statistical analyses undertaken. For each
data collection point and outcome measure, the num-
bers of non-responders were calculated and completion
rates were compared. The average caseload per therapist
is detailed.
Recruitment
The original recruitment target was 100 people over 6
months. However, recruitment was slower than expected
and changes to recruitment strategy were made in an at-
tempt to increase recruitment after 3 months. This in-
cluded focusing recruitment on a more direct service
user approach (face to face, posting packs and follow-up
phone calls). Following these changes, recruitment did
improve (see Fig. 2).
Over the course of 12 months 138 people were re-
corded as being formally screened for eligibility. This
number is based on data from the screening logs from
the NHS Research and Development offices. However, it
is likely the number that were eligible was much higher
as many participants were notified about the study more
informally via leaflets, posters and talking to their care
coordinators. Of those formally screened, 117 (84.8%)
met the eligibility defined for inclusion into the trial.
This 84.8% eligible is much higher than the 50–60%
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anticipated based on previous studies [21, 25]. A total of
72 participants were randomised into the trial giving a
recruitment rate of 61.5% (52.2% of screened partici-
pants then went on to enter the study), which was
higher than the 40% which was predicted. The flow of
participants can be seen in 2.
Follow-up, withdrawals and intervention attendance
There was good retention in the trial. All participants
were followed up at 3 month post randomisation, and a
subsample (n = 38) were also followed up at 6 months
(limited only due to time constraints of the end of the
study period). At 3 months, 59 of the 72 participants
completed the questionnaire (81.9%), split equally across
the two arms (n = 30 intervention, and n = 29 control).
Similarly, at 6 months 76.3% of participant due to
complete the questionnaire did (n = 29, 13 intervention
and 16 control). This shows that participants in both
arms are willing to be involved and retain in the study,
demonstrating that a future trial would have the ability
to retain participants.
Overall, ten participants (13.9%) withdrew from the
study. Two participants were withdrawn from follow-up
only, one after discussion with the lead investigator and
clinician (due to their poor mental state at the time of
follow-up) and the other gave no reasons (one in each
Fig. 1 Consort Diagram
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arm). Full withdrawal from the trial was requested by
four participants; two in each treatment arm. One per-
son changed their mind about taking part due to the
topic, and a further three gave no reason.
Thirty-six participants (50.0%) were randomised to the
intervention arm. The intervention was designed to con-
sist of 31-hour sessions. Nine of these participants
(25.0%) never started the intervention; five withdrew
from treatment prior to starting. The first session was
attended by 25 participants (69.4%), the second by 19
(52.8%) and the third by 18 (50.0%). However, several
(n = 5) participants requested to combine sessions, so
this might be an under-estimate of attendance. In total,
17 participants (47.2%) attended all three sessions and
22 participants were exposed to all the content (61.1% of
those initially randomised; 81.5% of those who started
the intervention). Table 1 presents the demographics of
the participants in intervention and control arm.
Sexual behaviour measure
The SERBAS asked participants to record the number of
sexual acts, and those that were unprotected, that had
been undertaken in the last 3 months. The percentage of
total sex acts (oral, vaginal and anal) that were under-
taken without protection is detailed by arm at each time
point, by gender in Table 2.
The number of participants in RESPECT was small,
and 50% of the sample reported no sexual acts within
the length of the study; this means that (like the reviews
undertaken previously [10, 13]) there is no evidence in
this study that the intervention has had a statistically sig-
nificant effect reducing the number of sexual acts under-
taken without protection. However, it can be seen from
Table 2 that there does appear to be reduction in our
population in those who received the intervention.
Intervention delivery
There were 11 different interventionists who delivered
the sessions. A total of 70 sessions were delivered. This
gives an average of 6.4 sessions per therapist however
there was wide range from 1 session to 28 sessions deliv-
ered per interventionist.. On average the sessions were
58min long (excluding the combined sessions) and had
been designed to be approximately 60 min long.
Health economics
Unit costs of health service use were obtained from the
UK national database of reference costs Department of
Health [26] [ref], and the Unit Costs of Health and So-
cial Care report produced by the Personal and Social
Services Resource Unit [ref] [27].
Qualitative feedback about the experience of
participation
A sub-sample of 22 people (in control and intervention
arms) were interviewed.
The results of the qualitative study are reported in
more detail in the NIHR report [19] but in summary the
participants were very positive about the whole experi-
ence of taking part in RESPECT. There was no overall
preference for any one method of recruitment, but there
was a common theme of stating a preference in being
able to have a conversation with someone about partici-
pating (such as with their care coordinator). This is in-
teresting to note considering care coordinators had not
engaged directly conversations about the study during
recruitment and the more successful route had been by
Fig. 2 Recruitment
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Table 1 Participant Demographics
Intervention (n = 36) Control (n = 36) Overall (n = 72)
Age
Mean (sd) 44.2 (12.1) 45.3 (11.5) 44.8 (11.8)
Median (min, max) 47.1 (22.9, 66.1) 46.9 (22.0, 65.1) 46.9 (22.0, 66.1)
Gender, n (%)
Male 18 (50.0) 17 (47.2) 35 (48.6)
Female 17 (47.2) 17 (47.2) 34 (47.2)
Other 1 (2.8) 2 (5.6) 3 (4.2)
Missing 0 (0.0) 0 (0.0) 0 (0.0)
Sexuality, n (%)
Heterosexual 29 (80.6) 30 (83.3) 59 (81.9)
Gay or lesbian 3 (8.3) 1 (2.8) 4 (5.6)
Bisexual 3 (8.3) 3 (8.3) 6 (8.3)
Prefer not to say 0 (0.0) 1 (2.8) 1 (1.4)
Other 1 (2.8) 1 (2.8) 2 (2.8)
Ethnicity, n (%)
White British 23 (63.9) 23 (63.9) 46 (63.9)
White Irish 0 (0.0) 1 (2.8) 1 (1.4)
Black African 1 (2.8) 1 (2.8) 2 (2.8)
Black Caribbean 2 (5.6) 0 (0.0) 2 (2.8)
Black Other 0 (0.0) 1 (2.8) 1 (1.4)
Asian Indian 1 (2.8) 1 (2.8) 2 (2.8)
Asian Pakistani 1 (2.8) 2 (5.6) 3 (4.2)
Asian Bangladeshi 1 (2.8) 0 (0.0) 1 (1.4)
Asian Other 0 (0.0) 1 (2.8) 1 (1.4)
White & Black Caribbean 1 (2.8) 0 (0.0) 1 (1.4)
White & Asian 0 (0.0) 1 (2.8) 1 (1.4)
Other mixed background 1 (2.8 0 (0.0) 1 (1.4
Prefer not to say 1 (2.8) 1 (2.8) 2 (2.8)
Other 4 (11.1) 4 (11.1) 8 (11.1)
Religion, n (%)
No religion 15 (41.7) 14 (38.9) 29 (40.3)
Muslim 3 (8.3) 3 (8.3) 6 (8.3)
Christian 14 (38.9) 13 (16.1) 27 (37.5)
Sikh 1 (2.8) 0 (0.0) 1 (1.4)
Buddhist 0 (0.0) 3 (0.0) 3 (4.2)
Hindu 0 (0.0) 0 (0.0) 0 (0.0)
Jewish 0 (0.0) 0 (0.0) 0 (0.0)
Prefer not to say 0 (0.0) 1 (2.8) 1 (1.4)
Other 1 (2.8) 1 (2.8) 2 (2.8)
Missing 2 (5.6) 1 (2.8) 3 (4.2)
Highest qualification, (%)
None 3 (8.3) 3 (8.3) 6 (8.3)
GCSEs/GCEs/CSEs 9 (25.0) 2 (5.6) 11 (15.3)
AS/A Levels 6 (16.7) 6 (16.7) 12 (16.7)
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direct contact with potential participants. The study in-
formation provided was reported to be easy to under-
stand and provided enough information to prepare them
for what would be involved in taking part. People found
the data collection comfortable and not distressing
despite the fact that for some people the data collection
appointments could be up to 2 h and involve questions
about sexual activity. They reported that the research
staff were friendly and approachable and they valued
flexibility in times and locations of appointments. They
appreciated the voucher as a “thank you” for taking part.
Some felt that parts of the data collection was a bit bor-
ing and repetitive, but not to the point that it was very
uncomfortable. For those who received the intervention,
they found it interesting, thought provoking and inform-
ative. They liked the interactive nature of the sessions
and again there were comments appreciating the flexibil-
ity of times and locations of delivery. Some of the
participants mentioned they had never spoken to a care
Table 1 Participant Demographics (Continued)
Intervention (n = 36) Control (n = 36) Overall (n = 72)
Diploma 1 (2.8) 3 (8.3) 4 (4.6)
Higher Degree 7 (19.4) 5 (13.9) 12 (16.7)
Further Higher Degree 2 (5.6) 5 (13.9) 7 (9.7)
Vocational Education 4 (11.1) 6 (16.7) 10 (13.9)
Other 3 (8.3) 5 (13.9) 8 (11.1)
Missing 1 (2.8) 1 (2.8) 2 (2. 8)
Employment, n (%)
Full time 1 (2.8) 5 (13.9) 6 (8.3)
Part time 4 (11.1) 3 (8.3) 7 (9.7)
Unable to work due to poor health 17 (47.2) 21 (58.3) 38 (52.8)
Unemployed 8 (22.2) 5 (13.9) 13 (18.1)
Retired 2 (5.6) 1 (2.8) 3 (4.2)
Student 2 (5.6) 1 (2.8) 3 (4.2)
Other 2 (5.6) 0 (0.0) 2 (2.8)
Living arrangement, n (%)
Live with parent/career 4 (11.1) 7 (19.4) 11 (15.3)
Live alone 24 (66.7) 18 (50.0) 42 (58.3)
Live with relative 1 (2.8) 3 (8.3) 4 (5.6)
Live in a hostel 2 (5.6) 1 (2.8) 3 (4.2)
Live with a friend 2 (5.6) 2 (5.6) 4 (5.6)
With partner/spouse 2 (5.6) 4 (11.1) 6 (8.3)
Other 1 (2.8) 1 (2.8) 2 (2.8)
Relationship status, n (%)
Single, not married 26 (72.2) 22 (61.1) 48 (66.7)
Married 2 (5.6) 5 (13.9) 7 (9.7)
Civil partnership 0 (0.0) 0 (0.0) 0 (0.0)
Co-habiting 2 (5.6) 0 (0.0) 2 (2.8)
In a relationship, not living together 4 (11.1) 6 (16.7) 10 (13.9)
Separated 0 (0.0) 1 (2.8) 1 (1.4)
Divorced 2 (5.6) 2 (5.6) 4 (5.6)
Widowed 0 (0.0) 0 (0.0) 0 (0.0)
Table 2 Percentage of total sex acts undertaken without
protection (condom or other barrier)
Time
point
Intervention Control
Males Females Males Females
Baseline 97 73 87 68
Month 3 85 59 78 75
Month 6 50 53 79 97
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coordinator about sexual health before, and one partici-
pant reported that taking part in RESPECT had been an
“ice breaker” meaning that they had begun to have con-
versations with their care coordinator about the subject.
Finally, almost all of the 22 participants said they would
recommend participating in the study to other people.
Discussion
The RESPECT study was the first study to test the feasibil-
ity of undertaking a randomised trial of a sexual health
intervention outside the Americas. Few studies related to
sex and sexuality have been conducted in the UK, and as
well as identifying if such as study is acceptable and feas-
ible, this also has provided useful data on how to recruit
to and collect data on sexual health for people who use
community mental health services.
As this was designed to establish feasibility, it was not
powered to detect statistically differences between inter-
vention and control group so despite the intervention
group outcomes appearing to favour a benefit from the
intervention, this has not been definitively established in
this study. The time to recruit the sample was in hind-
sight underestimated. The target of 100 was not
achieved, even with an extension to the recruitment
phase. However the attrition was not as high as the pre-
dicted 30%. The other limitation is a lack of detail on
exact numbers screened at each site, and how many of
those eligible actually received information regarding the
study. Therefore it is not known for sure if the lower
recruitment was due to the study being unattractive to
eligible participants, or if it was because the information
did not reach the potential participants. Certainly, the
recruitment did improve using a more direct approach
rather than relying on busy mental health staff to discuss
the study and pass on information. The participants who
were interviewed did not express a preference for re-
cruitment method but did feel that it was important to
be able to speak to someone (such as their care coordin-
ator about the study).
The profile of people recruited broadly reflect the
characteristics of people with serious mental Illness (see
Table 1). In addition to the demographics, the average
ReQoL scores reflect those of a clinical population [24].
Equal numbers of men and women were recruited and
evenly distributed across both arms. Retention was simi-
lar in both arms of the trial. The study was conducted
over several services and a range of geographical areas in
England therefore the challenges and solutions that have
been identified are likely to be applicable to further sites
in a larger trial.
The fact that 72 people with serious mental illness
across several services in England engaged with the
study is a positive finding. This indicates that it is feas-
ible to engage people with SMI in a study related to
sexual health without any adverse events. Retention was
good in terms of both the data collection (both in con-
trol and intervention group) in spite of the fact that data
collection appointments took between one and 2 h and
focused on sexual behaviour. The intervention was well
attended; most people who attended at least the first ses-
sion of the intervention went on to complete all three.
The feedback from the qualitative interviews comfirmed
that this was perceived to be a comfortable and interest-
ing study to participate in,
The feasibility study has identified a number of issues
that could be addressed in a future fully powered trial of
effectiveness: This includes dedicating more time to sup-
port the role of the care coordinators in community
mental health teams in terms of promoting the topic
and allaying any concerns regarding the study. In
addition, there should be sufficient people trained and
able to deliver the intervention within each service (and
of both genders). There were periods in the study where
there was a lack of availability of a trained intervention-
ist, and some participants did not receive the interven-
tion due to this delay.
Many people were not sexually active during the study
period (even if they had been active in other periods)
and so this means that the primary outcome of N%
“condom less sex” could be problematic to base the sam-
ple size calculation for a future trial. However, the
intervention sought to be broader than simply using
condoms, and also includes the whole range of contra-
ceptive choices, as well as assertiveness skills and plan-
ning within sexual relationships, in line with the World
Health Organisation [28] definition. This sees sexual
health as broader than simply the prevention of infec-
tions; and incorporates the right to express one’s own
sexuality free from abuse and coercion. The RESPECT
study gave people an opportunity to have frank discus-
sions about their past current and future sexual encoun-
ters, as well as receiving a clear message that sexual
expression is important part of being human and having
a mental illness should not exclude them from what is
actually a fundamental human right. One of the measures
assessed behavioural intentions to adopt safer sex and at
follow-up the scores were positive in the direction of the
intervention. Therefore it will be important in a future
trial that people are not excluded on the basis of not being
currently sexually active, and the sample size will have to
be larger to account for the fact that some people may not
be having sex during the study period itself.
Despite not quite achieving the target sample, at
the end of recruitment period there were other po-
tential recruits identified, and the recruitment graph
suggests that recruitment improved over time, so it is
reasonable to assume that targets could be achieved
in a future trial with sufficient sites fully engaged and
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with capacity to deliver on the intervention for the
trial period.
Conclusion
People with serious mental illness are interested in sex-
ual health and have a range of sexual health needs that
need exploring and responding to. This study was able
to recruit a sample of people who are living with serious
mental illness and retain them in both the intervention
and data collection. The topic did not trigger distress or
other harms. Therefore undertaking sexual health re-
search with people with serious mental illness is import-
ant, and this study demonstrated that it is feasible, safe
and acceptable to participants.
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